Stocks
Biogen (BIIB) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| EBITDA margin, % | ? | 35.7% | 34.8% | 24.2% | 31.0% | 30.0% | 28.3% | ||
| Changes by years, y/y, % | -2pp | -1pp | -11pp | +7pp | -1pp | 31% | |||
Biogen. EBITDA margin, %
Biogen. EBITDA margin, changes, pp
Biogen (BIIB) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 42.0% | 33.7% | 2.49% | 25.1% | 16.5% | 28.3% | |
| Changes by years, y/y, % | +3pp | +5pp | -26pp | -11pp | -25pp | |||
| Changes by quarters, q/q, % | +6pp | -8pp | -31pp | +23pp | -9pp | |||
